Skip to main content
. 2020 Nov 13;21(22):8547. doi: 10.3390/ijms21228547

Figure 1.

Figure 1

Schematic representation of the mechanism underlying the synergistic antitumor effects of S-adenosylmethionine and doxorubicin in CG5 breast cancer cells.

HHS Vulnerability Disclosure